E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/24/2023 in the Prospect News Structured Products Daily.

New Issue: GS Finance sells $732,000 callable contingent coupon notes on ETFs

By Kiku Steinfeld

Chicago, July 24 – GS Finance Corp. priced $732,000 of callable contingent coupon ETF-linked notes due Feb. 25, 2030 linked to the SPDR S&P Biotech ETF and Technology Select Sector SPDR Fund, according to a 424B2 filing with the Securities and Exchange Commission.

The notes are guaranteed by Goldman Sachs Group, Inc.

The notes will pay a contingent monthly coupon at an annualized rate of 6.15% if each ETF closes at or above its 80% coupon trigger level on the determination date for that period.

The notes will be callable at par plus any contingent coupon due at the issuer’s option on any quarter coupon payment date after one year.

If the notes are not called, the payout will be par plus any final coupon.

Goldman Sachs & Co. LLC is the agent.

Issuer:GS Finance Corp.
Guarantor:Goldman Sachs Group, Inc.
Issue:Callable contingent coupon ETF-linked notes
Underlying ETFs:SPDR S&P Biotech ETF and Technology Select Sector SPDR Fund
Amount:$732,000
Maturity:Feb. 25, 2030
Contingent coupon:6.15% per year, payable monthly if each ETF closes at or above coupon trigger level on determination date
Price:Par
Payout at maturity:Par
Call:At par plus any contingent coupon at issuer’s option on any quarterly coupon payment date after one year
Initial levels:$86.80 for biotech, $139.82 for technology
Coupon trigger levels:80% of initial levels
Pricing date:Feb. 17, 2023
Settlement date:Feb. 23, 2023
Agent:Goldman Sachs & Co. LLC
Fees:4.125%
Cusip:40057PPX4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.